Eltrombopag has a certain therapeutic effect on aplastic anemia, Eltrombopag has the effect of promoting platelet production. Aplastic anemia is a disease in which the blood cells produced by oneself are not enough to compensate for the metabolism of one’s own blood cells, and the patient will show symptoms such as fatigue and bleeding, etc. Patients with aplastic anemia can alleviate the symptoms by stimulating the production of one’s own blood cells. Eltrombopag is a platelet receptor agonist, which can increase the number of megakaryocytes in the body, and at the same time, it can promote the differentiation of megakaryocytes, thus increasing the number of platelets, therefore, Eltrombopag can be used for the treatment of aplastic anemia. Common adverse reactions to Eltrombopag include nausea, vomiting, muscle pain, cataracts, and indigestion. It should be used with caution in patients with impaired liver function, pregnant and lactating women, and the elderly. Eltrombopag can treat aplastic anemia, and it is recommended that patients with aplastic anemia choose the appropriate treatment medication according to their symptoms under the guidance of a doctor.